reports
ContextVision – Mandatory notification of trade – primary insider
ContextVision – Mandatory notification of trade – primary insider STOCKHOLM – August 28, 2020 – Ola Lindblad, VP Medical Imgaing of ContextVision, has on August 27, 2020 purchased 1,800 shares in ContextVision AB at an average price of NOK 22.37 per share. After the transaction, Mr Lindblad holds a total of 6,300 shares in ContextVision AB. For further information, please contact ContextVision’s CEO, Fredrik Palm, at 3 or visit . ### About ContextVision ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market...
ContextVision – Mandatory notification of trade – primary insider
ContextVision – Mandatory notification of trade – primary insider STOCKHOLM – August 17, 2020 – Fredrik Palm, CEO of ContextVision, has on August 17, 2020 purchased 200 shares in ContextVision AB at an average price of NOK 245 per share. After the transaction, Mr Palm holds a total of 2,820 shares in ContextVision AB. For further information, please contact ContextVision’s CEO, Fredrik Palm, at 3 or visit . ### About ContextVision ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image en...
ContextVision – key information relating to share split
ContextVision – key information relating to share split STOCKHOLM – Aug 13, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announces key information relating to the share spilt after a decision by the Board of Directors as of August 12th 2020. Reference is made to the extraordinary general meeting of ContextVision, held on August 5th, 2020 where it was decided to increase the number of shares in the company by dividing each share into ten shares (share split 10:1). The Board of Directors was authorized to determ...
ContextVision’s second quarter sees multiple product releases includ...
ContextVision’s second quarter sees multiple product releases including digital pathology debut STOCKHOLM – Aug 13, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today reports a progressive second quarter. INIFY® Prostate Screening – the company’s first decision support tool in a planned digital pathology portfolio – was granted CE-mark status, paving the way for a strong entry into the fast-growing digital pathology market. In addition, the company continues to spearhead the image enhancement market with its new next...
ContextVision: Flere produktlanseringer i andre kvartal inkludert før...
ContextVision: Flere produktlanseringer i andre kvartal inkludert første innen digital patologi STOCKHOLM - 13. august 2020 – ContextVision, et medisinsk teknologiprogramvarefirma som spesialiserer seg på bildeanalyse og kunstig intelligens, rapporterer i dag om et progressivt andre kvartal. INIFY® Prostata Screening – selskapets første beslutningsstøtteverktøy i en planlagt portefølje innen digital patologi – fikk status som CE-merke, som banet vei for en sterk inntreden i det raskt voksende markedet for digital patologi. I tillegg fortsetter selskapet å lede an i markedet for forbedring a...
ContextVision Extraordinary General Meeting
ContextVision Extraordinary General Meeting On the 5th of August 2020, ContextVision held an Extraordinary General Meeting in Stockholm. The Board's proposal for adoption of new articles of association was approvedThe Board's proposal for decision on the share split of the company's share was approvedNo other matters were processed at the meeting. For further information, please contact:Ann-Charlotte Linderoth (CFO) tel +46 (0)8 7503550, e-mail ### About ContextVision ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As...
ContextVision lanserar första CE-märkta digitala patologiprodukten
ContextVision lanserar första CE-märkta digitala patologiprodukten STOCKHOLM – 29 juni 2020 – ContextVision AB, ett medicintekniskt mjukvaruföretag som specialiserat sig på bildanalys, bildbehandling och artificiell intelligens, meddelade idag att dess första produkt i en planerad portfölj för digital patologi har fått CE-märkesstatus. Detta innebär att INIFY® Prostate Screening nu är tillgänglig för klinisk användning inom EU. “Jag är stolt över det fantastiska resultat som vårt enastående team har åstadkommit för att nå denna viktiga milstolpe för företaget. Sjukvårdssystem runt om i vä...
ContextVision announces first CE marked digital pathology product
ContextVision announces first CE marked digital pathology product STOCKHOLM – June 29, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announced that its first digital pathology product in a planned portfolio has been granted CE mark status. This means that INIFY® Prostate Screening is now available for routine clinical use within the European Union. “I am proud of the great performance by our outstanding multidisciplinary team in reaching this company milestone. Healthcare systems around the world are already...
ContextVision lanserer sitt første digitale patologiprodukt med CE-me...
ContextVision lanserer sitt første digitale patologiprodukt med CE-merking STOCKHOLM - 29 juni, 2020 – ContextVision, et medisinsk teknologiprogramvarefirma som spesialiserer seg på bildeanalyse og kunstig intelligens, kunngjorde i dag at det første digitale patologiproduktet i en planlagt portefølje, har fått CE-merkestatus. Dette betyr at INIFY® Prostate Screening nå er tilgjengelig for rutinemessig klinisk bruk i EU. «Jeg er stolt over den fantastiske jobben vårt fremragende flerfaglige team har gjort, når det gjelder å nå denne viktige milepælen for selskapet. Verdens helsevesen er al...
ContextVision – Invitation to Extraordinary General Meeting 2020
ContextVision – Invitation to Extraordinary General Meeting 2020 STOCKHOLM – June 24, 2020 – ContextVision hereby invites shareholders to an Extraordinary General Meeting on August 5, 2020. Please find attached the invitation including agenda and details on how to register. Please contact: for any questions regarding the Extraordinary General Meeting. For inquiries, please contact CFO Ann-Charlotte LinderothE-mail: ### About ContextVision ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader with...
ContextVision – Kallelse till extra bolagsstämma 2020
ContextVision – Kallelse till extra bolagsstämma 2020 STOCKHOLM – 24 juni, 2020 – ContextVision kallar härmed aktieägare till extra bolagsstämma den 5:e augusti 2020. Bifogat finns kallelse inklusive dagordning och instruktioner för registrering. Vänligen kontakta: för frågor gällande den extra bolagsstämman. För övriga frågor, vänligen kontakta CFO Ann-Charlotte LinderothE-post: ### Om ContextVisionContextVision är ett medicintekniskt mjukvaruföretag specialiserat på bildanalys och artificiell intelligens. Som den globala marknadsledaren inom bildbehandling är vi en etablerad partn...
ContextVision - Company presentation held at SpareBank 1 Markets Webin...
ContextVision - Company presentation held at SpareBank 1 Markets Webinar Stockholm, June 12th, 2020 – Today ContextVision presented the company at a webinar arranged by SpareBank 1 Markets in Norway. CEO Fredrik Palm gave an update of the company’s development and shared the company’s future direction. Please find a PDF-version of the presentation attached. The presentation will also be published on the company's website. For further information, please contact ContextVision’s CEO, Fredrik Palm, at 3 or visit . ### About ContextVision ContextVision is a medical technology software com...
ContextVision – Mandatory notification of trade – primary insider
ContextVision – Mandatory notification of trade – primary insider STOCKHOLM – May 19, 2020 – Fredrik Palm, CEO of ContextVision, has on May 19, 2020 purchased 120 shares in ContextVision AB at an average price of NOK 155 per share. After the transaction, Mr Palm holds a total of 2620 shares in ContextVision AB. For further information, please contact ContextVision’s CEO, Fredrik Palm, at 3 or visit . ### About ContextVision ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhanceme...
ContextVision strengthens board with strategic healthcare competence
ContextVision strengthens board with strategic healthcare competence STOCKHOLM – May 12, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announced the strengthening of its board of directors. Martin Ingvar, Professor of Integrative Medicine at Karolinska Institute Sweden and founding member of International Consortium for Health Outcome Measurements (ICHOM), was elected as new member of the board at the annual general meeting. The company will soon enter the rapidly emerging digital pathology market with its f...
ContextVision Annual General Meeting
ContextVision Annual General Meeting On the 6th of May 2020, ContextVision held its ordinary Shareholders' Annual General Meeting in Stockholm. The annual financial report regarding 2019 was presented and approved by the AGM.Disposition of financial results according to the proposal of the Board of Directors was approved.The Managing Director and the Board of Directors were discharged from liability.The proposed guidelines for remuneration to the Board of Directors and senior executives was approved.Board compensation was decided according to the following: The chairman of the board will b...
ContextVision stock-based incentive program - share transactions
ContextVision stock-based incentive program - share transactions Stockholm, May 6, 2020 The ContextVision AB:s Profit Sharing Foundation has sold and purchased shares in ContextVision AB in accordance with the rules related to the foundation. The ContextVision AB:s Profit Sharing Foundation has sold 30,500 shares on April 28, at an average price of 120 NOK/share, in accordance with the rules related to the foundation. The sold shares were originally purchased in 2015, and according to the rules they must be sold after a period of 3 full calendar years, the year of purchase thereby not inc...
ContextVision – Mandatory notification of trade – primary insider
ContextVision – Mandatory notification of trade – primary insider STOCKHOLM – April 29, 2020 – Fredrik Palm, CEO of ContextVision, has on April 28, 2020 purchased 1000 shares in ContextVision AB at an average price of NOK 120 per share. After the transaction, Mr Palm holds a total of 2500 shares in ContextVision AB. Monsun AS, controlled by Magne Jordanger, member of the board of ContextVision, has on April 28, 2020 purchased 2000 shares in ContextVision AB at an average price of NOK 120 per share. After the transaction, Monsun AS holds a total of 2 300 000 shares in ContextVision AB whic...
ContextVision Sees Strongest Quarter Ever with Record Sales and Produc...
ContextVision Sees Strongest Quarter Ever with Record Sales and Product Momentum within Digital Pathology STOCKHOLM – April 23, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announced record sales and EBITDA, mainly driven by the company’s medical imaging business, despite the current global challenges. ContextVision’s first digital pathology solution continues to accelerate toward market availability. Medical Imaging Sales in Q1 ended at 29.2 MSEK, a substantial increase of 38.4% compared to the first quart...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.